Alzamend NeuroALZN
13F holders, Q3 2025 (September 30)11holders +4
5new positions
0sold out
$2.38avg. 13F price*
At the end of Q3 2025, 11 institutions reported holding Alzamend Neuro Inc. (ALZN) in their 13F filings, up 4 from Q2 2025. 5 opened new positions and 0 sold out. The largest holders were DRW Securities, LLC ($217K), Vanguard Group Inc. ($51K) and Geode Capital Management, LLC ($49K).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $341K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 145,444 shares bought and 6 shares sold, net +145,438 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| DRW Securities, LLC | 0.01% | New | 91,245 | $217K |
| Vanguard Group Inc. | 0.00% | New | 21,620 | $51K |
| Geode Capital Management, LLC | 0.00% | New | 20,578 | $49K |
| Clearstead Advisors, LLC | 0.00% | New | 10,000 | $24K |
| UBS Group AG | 0.00% | Add +130.0% | 2,075 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +101.5% | 1,606 | $4K |
| BlackRock, Inc. | 0.00% | Reduce -0.9% | 437 | $1K |
| Bank of America Corp. | 0.00% | Add +94.7% | 37 | $88 |
| SBI Securities Co., Ltd. | 0.00% | No change | 22 | $52 |
| Citigroup Inc. | 0.00% | New | 1 | $2 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is ALZN's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.